It is noteworthy that similar levels of efficacy were demonstrated with the ABT-199/MLN8237 combination as the ABT-263/MLN8237 combination in the MYCN-amplified neuroblastoma cells (Figures S6E and S6F). The gene discussed is MYCN; the disease is neuroblastoma.